OMNIAB, INC. Investment Income, Interest
OMNIAB, INC. (OABI) reported Investment Income, Interest of $434.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-06
- OMNIAB, INC. investment income, interest for the quarter ending 2026-06-30 was $434.00K, a 0.46% decline year-over-year.
- OMNIAB, INC. investment income, interest for the quarter ending 2026-03-31 was $487.00K, a 9.31% decline year-over-year.
- OMNIAB, INC. investment income, interest for the quarter ending 2025-12-31 was $1.23M, a 87.02% increase year-over-year.
- OMNIAB, INC. investment income, interest for the quarter ending 2025-09-30 was $462.00K, a 33.14% decline year-over-year.
- OMNIAB, INC. investment income, interest for fiscal 2025 was $2.66M, a 14.36% decline from fiscal 2024.
- OMNIAB, INC. investment income, interest for fiscal 2024 was $3.11M, a 38.56% decline from fiscal 2023.
- OMNIAB, INC. investment income, interest for fiscal 2023 was $5.05M, a 761.16% increase from fiscal 2022.
- OMNIAB, INC. investment income, interest for fiscal 2022 was $587.00K.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $434.00K 10-Q · filed 2026-08-06 | $921.00K 10-Q · filed 2026-08-06 | $2.15M derived: sum of 3 quarters · filed 2026-08-06 | $2.61M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $487.00K 10-Q · filed 2026-05-07 | $1.71M derived: sum of 2 quarters · filed 2026-05-07 | $2.17M derived: sum of 3 quarters · filed 2026-05-07 | $2.61M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $1.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $1.69M derived: sum of 2 quarters · filed 2026-03-04 | $2.12M derived: sum of 3 quarters · filed 2026-08-06 | $2.66M 10-K · filed 2026-03-04 |
| 2025-09-30 | $462.00K 10-Q · filed 2025-11-04 | $898.00K derived: sum of 2 quarters · filed 2026-08-06 | $1.44M 10-Q · filed 2025-11-04 | $2.09M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $436.00K 10-Q · filed 2026-08-06 | $973.00K 10-Q · filed 2026-08-06 | $1.63M derived: sum of 3 quarters · filed 2026-08-06 | $2.32M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $537.00K 10-Q · filed 2026-05-07 | $1.19M derived: sum of 2 quarters · filed 2026-05-07 | $1.88M derived: sum of 3 quarters · filed 2026-05-07 | $2.67M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $655.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $1.35M derived: sum of 2 quarters · filed 2026-03-04 | $2.13M derived: sum of 3 quarters · filed 2026-03-04 | $3.11M 10-K · filed 2026-03-04 |
| 2024-09-30 | $691.00K 10-Q · filed 2025-11-04 | $1.48M derived: sum of 2 quarters · filed 2025-11-04 | $2.45M 10-Q · filed 2025-11-04 | $3.63M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $785.00K 10-Q · filed 2025-08-06 | $1.76M 10-Q · filed 2025-08-06 | $2.94M derived: sum of 3 quarters · filed 2025-08-06 | $4.21M derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | $975.00K 10-Q · filed 2025-05-08 | $2.16M derived: sum of 2 quarters · filed 2025-05-08 | $3.42M derived: sum of 3 quarters · filed 2025-05-08 | $4.71M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $2.45M derived: sum of 2 quarters · filed 2025-03-18 | $3.73M derived: sum of 3 quarters · filed 2025-03-18 | $5.05M 10-K · filed 2025-03-18 |
| 2023-09-30 | $1.26M 10-Q · filed 2024-11-12 | $2.55M derived: sum of 2 quarters · filed 2024-11-12 | $3.87M 10-Q · filed 2024-11-12 | $4.46M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $1.28M 10-Q · filed 2024-08-08 | $2.61M 10-Q · filed 2024-08-08 | $3.20M derived: sum of 3 quarters · filed 2024-08-08 | $3.20M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $1.32M 10-Q · filed 2024-05-09 | $1.91M derived: sum of 2 quarters · filed 2024-05-09 | $1.91M derived: sum of 3 quarters · filed 2024-05-09 | $1.91M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $587.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $587.00K derived: sum of 2 quarters · filed 2024-03-25 | $587.00K derived: sum of 3 quarters · filed 2024-03-25 | $587.00K 10-K · filed 2024-03-25 |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-10 | $0.00 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | $0.00 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |